News
Stay Ahead with the Latest Industry Trends & Market Insights with Industry News 📰

Computational Biology Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: September 2024 || SKU: HCIT1701
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables And Figures
Get Free Sample

See how US Tariffs impact Computational Biology Market

Don’t get caught off guard!

Global Computational Biology Market is segmented By Application (Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software) By Tool (Databases, Infrastructure, Analysis Software and Services) By Service (In-House, Contract) By End User (Academic & Research, Industrial, Commercial, Others) and By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

 

Report Overview

Global Computational Biology market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.

Computational biology is an exciting and quickly expanding field that blends the complexity of biological systems with the power of computers. It analyzes, interprets, and comprehends biological data, from genes and proteins to entire ecosystems, using computational and analytical approaches.

A computational biologist builds models to gain a deeper understanding of biological processes using biological data. uses massive data sets and computational and mathematical techniques to do analysis. It involves the representation and simulation of biological systems as well as the interpretation of experimental data, frequently on a very large scale, through the application of computer techniques.

 

Market Scope

Metrics

Details

CAGR

YY%

Market Size Available for Years

2022-2031

Estimation Forecast Period

2024-2031

Revenue Units

Value (US$ Mn)

Segments Covered

Application, Tool, Service, End user

Regions Covered

North America, Europe, Asia-Pacific, South America, and Middle East & Africa

Largest Region

North America

Fastest Growing Region

Asia-Pacific

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.

 

For more details on this report,Request for Sample

 

Market Dynamics: Drivers & Restraints

Increase in research activities for drug discovery processes  

The increase in research and developmental activities in drug discovery and at the molecular level is expected to drive market growth. The introduction of new databases and new software for drug discoveries and development is expected to drive market growth. 

For instance, in October 2023, BioBam introduced OmicsBox 3.1, its latest version packed with innovative features designed to empower researchers, scientists, and bioinformaticians in their pursuit of advanced omics data analysis and interpretation.

Additionally, in January 2024, Uppaluri K&H Personalized Medicine Clinic unveiled GeneConnectRx, the diagnostic wing of the K&H clinic. It is expected that the discovery of a revolutionary step in personalized medicine will mark a paradigm shift, empowering healthcare providers to customize treatments based on individual genetic makeup. Thus, the above factors are expected to drive the market growth.

Lack of skilled resources to operate computational tools   

Lack of professionals in the field is expected to hamper the market growth. It requires a unique blend of skills in biology, data science, computer science, and statistics to work in computational biology. Thus, finding experts with extreme knowledge can be difficult and is expected to hinder market growth.

Market Segment Analysis

The global computational biology market is segmented based on the application, tool, service, end user and region.

Cellular & Biological Simulation segment is expected to dominate the market share 

The cellular and biological simulation segment is expected to hold the dominant position. The increase in research and development and the increase in investments and grant funds are expected to drive the segment growth and are expected to hold the segment in the dominant position in the forecast period.

For instance, in November 2022, Turbine Ltd., a U.K.-based cell behavior simulation company declared the closing of a US$ 20 million series financing round. 

Additionally, in June 2022, Certara released new versions of its Immunogenicity (IG), Immuno-oncology (IO) and Vaccine Simulators to help predict how drugs work and address key questions in the development of novel biological therapies.

Market Geographical Analysis

North America is expected to hold a significant position in computational biology market share

North America has been dominant in the computational biology market share and is expected to continue throughout the forecast period. The research and development carried out in the region and also the investments and funding in the field have been holding the region in the dominant position.

For instance, in August 2023, the U.S. Department of Energy (DOE) declared $4.7 million in funding for five new research projects in computational biology. These projects will develop new software and analytical tools to manage the growing quantities of genomics and other data stemming from the study of microbes and other biological systems. 

Additionally, in September 2023, it was stated that the NSF Science and Technology Center for Quantitative Cell Biology would be at the Beckman Institute for Advanced Science and Technology and supported by a $30 million U.S. National Science Foundation grant. Thus, the above factors are expected to hold the region in the dominant position in the forecast period.

COVID-19 Impact Analysis

COVID-19 has impacted the market growth. Closures and restrictions on laboratories affected ongoing research initiatives and data collection activities. This slowed down advancement in a number of fields, including the creation of vaccines and new drugs. Funding and resources were redirected to the pandemic response immediately, which would have slowed down research in other computational biology-related fields.

Market Competitive Landscape

The major global players in the market include Simulations Plus Inc., Insilico Biotechnology AG, Compugen Ltd., Certara., Nimbus Therapeutics., Athos Therapeutics, Thermo Fisher Scientific Inc., Schrödinger, Inc., Fios Genomics, Illumina, Inc. among others.

Why Purchase the Report?

  • To visualize the global computational biology market segmentation based on the application, tool, service, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development. 
  • Excel data sheet with numerous data points of the computational biology market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global computational biology market report would provide approximately 55 tables, 58 figures and 180 pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Why purchase Computational Biology Market report?

Technological Innovations

Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.

Product Performance & Market Positioning

Analyzes product performance, market positioning, and growth potential to optimize strategies.

Real-World Evidence

Integrates patient feedback and data into product development for improved outcomes.

Physician Preferences & Health System Impact

Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.

Market Updates & Industry Changes

Covers recent regulatory changes, new policies, and emerging technologies.

Competitive Strategies

Analyzes competitor strategies, market share, and emerging players.

Pricing & Market Access

Reviews pricing models, reimbursement trends, and market access strategies.

Market Entry & Expansion

Identifies optimal strategies for entering new markets and partnerships.

Regional Growth & Investment

Highlights high-growth regions and investment opportunities.

Supply Chain Optimization

Assesses supply chain risks and distribution strategies for efficient product delivery.

Sustainability & Regulatory Impact

Focuses on eco-friendly practices and evolving regulations in healthcare.

Post-market Surveillance

Uses post-market data to enhance product safety and access.

Pharmacoeconomics & Value-Based Pricing

Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

Target Audience 2025

Manufacturers

Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.

Regulatory & Policy

Compliance Officers, Government, Health Economists, Market Access Specialists.

Application & Innovation

AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.

Investors

Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.

Consulting & Advisory

Healthcare Consultants, Industry Associations, Analysts.

Supply Chain

Distribution and Supply Chain Managers.

Consumers & Advocacy

Patients, Advocacy Groups, Insurance Companies.

Academic & Research

Academic Institutions.

Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
  Get Free Sample
  Request new version
  Customize Sample
  Demo Full Report
Chat on WhatsApp
FAQ’s

  • North America is expected to hold a significant position in computational biology market share

  • Key players are Simulations Plus Inc., Insilico Biotechnology AG, Compugen Ltd., Certara, Nimbus Therapeutics, Athos Therapeutics, Thermo Fisher Scientific Inc., Schrödinger, Inc., Fios Genomics, and Illumina, Inc.
Related Reports
pharmaceuticals iconpharmaceuticals

Bioinformatics Services Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 December 19

Starting from

$4350

biotechnology iconbiotechnology

Genomics Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2025 March 20

Starting from

$4350

clinical-diagnostics iconclinical-diagnostics

Companion Diagnostics Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 July 16

Starting from

$4350

WhatsApp